Mutations of the gene expressing plasma membrane transporter for thyroid hormones MCT8 (SLC16A2) in humans lead to altered thyroid hormone levels and a severe neurodevelopmental disorder. Genetically engineered defect of the Mct8 gene in mice leads to similar thyroid hormone abnormalities but no obvious impairment of brain development or function. In this work we studied the relative role of the blood-brain barrier and the neuronal plasma cell membrane in the restricted access of T 3 to the target neurons. To this end we compared the effects of low doses of T he importance of plasma membrane transporters for the transfer of thyroid hormones from the extracellular milieu to the interior of the cell is now widely recognized. For many years it was thought that thyroid hormones enter the target cells by passive or facilitated diffusion. However mutations in a specific T 4 and T 3 transporter, the monocarboxylate transporter 8 (MCT8, SlC16A2), were found in patients with a severe neurodevelopmental defect and abnormal levels of iodothyronines in blood, consisting of decreased T 4 and rT 3 and increased T 3 (1, 2). These and subsequent findings revealed the physiological role of transporters in thyroid hormone action and their relevance to the brain (3-5).
Mutations of the gene expressing plasma membrane transporter for thyroid hormones MCT8 (SLC16A2) in humans lead to altered thyroid hormone levels and a severe neurodevelopmental disorder. Genetically engineered defect of the Mct8 gene in mice leads to similar thyroid hormone abnormalities but no obvious impairment of brain development or function. In this work we studied the relative role of the blood-brain barrier and the neuronal plasma cell membrane in the restricted access of T 3 to the target neurons. To this end we compared the effects of low doses of T 4 and T 3 on cerebellar structure and gene expression in wild-type (Wt) and Mct8 null male mice [Mct8-/y, knockout (KO)] made hypothyroid during the neonatal period. We found that compared with Wt animals, T 4 was considerably more potent than T 3 T he importance of plasma membrane transporters for the transfer of thyroid hormones from the extracellular milieu to the interior of the cell is now widely recognized. For many years it was thought that thyroid hormones enter the target cells by passive or facilitated diffusion. However mutations in a specific T 4 and T 3 transporter, the monocarboxylate transporter 8 (MCT8, SlC16A2), were found in patients with a severe neurodevelopmental defect and abnormal levels of iodothyronines in blood, consisting of decreased T 4 and rT 3 and increased T 3 (1, 2) . These and subsequent findings revealed the physiological role of transporters in thyroid hormone action and their relevance to the brain (3) (4) (5) .
The generation of Mct8 knockout (KO) mice demonstrated that absence of Mct8 impairs brain thyroid hormone uptake and metabolism, possibly due to a primary decreased uptake and degradation of T 3 in target neurons (6, 7) . As a consequence, T 3 concentrations increase in serum, with stimulation of Dio1 expression in liver and other tissues. It is postulated that the increased Dio1 activity increases conversion of T 4 to T 3 , thereby decreasing T 4 and further increasing T 3 in serum. On the other hand, circulating rT 3 is also decreased, which might be due to increased degradation by Dio1 and/or decreased formation from T 4 by inner ring deiodination.
However, whereas the absence of Mct8 in mice reproduces the endocrine changes characteristic for humans with MCT8 gene mutations, the mutant mice do not show signs of neurological impairment, which contrasts with the observations in humans. It is logical to think that the neurological syndrome is due to impaired T 3 action in neurons as a consequence of restricted uptake. However, no histological changes suggestive of cerebral hypothyroidism in the mutant mice have been found, and only a moderately decreased expression of thyroid hormone regulated genes such as neurogranin (Nrgn, also known as RC3) could be related to the decreased T 3 uptake (6, 7). At least in part, this could be interpreted as if the mice brains were in a state of locally compensated hypothyroidism because Dio2 activity is increased in the brain due to the decreased concentration of circulating T 4 (6, 7) .
Early studies on Mct8 gene expression in rodents indicated that the gene is expressed predominantly in the choroid plexuses and in neurons (8) . Recent studies have shown that Mct8 is also expressed in the blood-brain barrier (9) . Other thyroid hormone transporters are expressed in the blood-brain barrier, such as organic anion transporters and L-type amino acid transporters (10, 11) . In the absence of Mct8, the restriction to T 3 transport through the blood-brain barrier or through the neuronal plasma membrane would depend on the presence of alternative transporters.
In this work, we studied the relevance of Mct8 gene expression in neurons for T 3 action. We have analyzed the relative effects of low doses of T 4 and T 3 on two T 3 target genes, expressed in the striatum (Nrgn) and cerebellum [Hairless (Hr)]. We found that in male Mct8KO mice, when compared with wild-type (Wt) mice, these genes are less responsive to T 3 than T 4 , indicating a restricted entry of plasma T 3 but not T 3 derived from T 4 . On the other hand, the action of T 3 in primary cultures of cerebellar granular cells was little affected in the absence of Mct8. The data suggest that the critical restriction to T 3 transport in the absence of Mct8 is located at the blood-brain barrier rather than at the plasma membrane of individual neurons.
Materials and Methods

Animals
Protocols for animal handling were approved by the local institutional Animal Care Committee, and followed the rules of the European Union. Animals were housed in temperature-(22 Ϯ 2 C) and light (12 h light, 12 h dark cycle; lights on at 0700 h)-controlled conditions and had free access to food and water. Mct8KO mice were originally produced by Dumitrescu et al. (6) by homologous recombination. Experiments were carried out on Wt (Mct8 ϩ/y ) and KO (Mct8-/y) male litter mates derived from the third and fourth back crossing of heterozygous females (Mct8 Ϫ/ϩ ) with Wt (Mct8 ϩ/y ) males of the C57BL/6J strain. The genotype was confirmed by PCR of tail DNA (38 cycles at 55 C annealing temperature) using the following primers: forward common, 5Ј-ACAA-CAAAA AGCCAAGCATT-3Ј; reverse Wt specific, 3Ј-GAGAG-CAGCGTAAGGACAAA-5Ј; reverse knockout specific, 3Ј-CTCCCA AGCCTGATTTCTAT-5Ј. Using this procedure the Wt allele generated a 476-bp products and the null allele a 239-bp PCR product.
Induction of hypothyroidism and thyroid hormone treatments
After crossing with Wt male mice, Mct8 ϩ/Ϫ pregnant dams were given either drinking water or a solution containing 0.02% 1-methyl-2-mercapto-imidazol (Sigma Chemical Co., St. Louis, MO) plus 1% KClO 4 ad libitum. These antithyroid drugs were given from gestational d 17, and throughout the lactating period, until the end of the experiment on postnatal day (P) 21. The pups were genotyped on P11 to select for Mct8 ϩ/y and Mct8 Ϫ/y mice from the same litters. For simplicity, these animals will be referred to as Wt and KO mice, respectively, throughout this paper. The hypothyroid pups were then divided into three groups receiving no hormonal treatment, 20 ng T 4 per gram body weight, or 3 ng T 3 per gram body weight respectively. The hormones were administered in PBS containing 0.1% BSA, as daily single ip injections from P16 to P20. The following groups were thus prepared: euthyroid (n ϭ 7) and hypothyroid (n ϭ 6) Wt mice; euthyroid (n ϭ 8) and hypothyroid (n ϭ 6) KO mice; hypothyroid Wt mice treated with either T 4 (n ϭ 5) or T 3 (n ϭ 6), and hypothyroid KO mice treated with either T 4 (n ϭ 6) or T 3 (n ϭ 6). The pups were killed by decapitation 24 h after the last T 4 or T 3 injection, on P21. The striatum and cerebellum were rapidly dissected out, frozen on dry ice, and kept at Ϫ80 C until RNA isolation.
Histological methods
Examination of stained sections of the cerebellum and in situ mRNA hybridization analysis were performed on pups perfused with paraformaldehyde under anesthesia. Methods for perfusion, sectioning, staining, and in situ hybridization have been previously described in detail (12, 13) .
PCR
Total RNA was extracted using the TRIZOL reagent (Invitrogen, Carlsbad, CA). cDNA was prepared from 250 ng RNA using the high capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). For quantitative PCR, a cDNA aliquot corresponding to 5 ng of the starting RNA was used, with Taqman Assay-on-Demand primers and the Taqman universal PCR master mix, No Amp Erase UNG (Applied Biosystems), on a 7900HT fast real-time PCR system (Applied Biosystems). The PCR program consisted in a hot start of 95 C for 10 min, followed by 40 cycles of 15 sec at 95 C and 1 min at 60 C. PCRs were performed in triplicates, using the 18S gene as internal standard and the 2-cycle threshold method for analysis. For quantitative assays, a standard curve was generated after amplification of known amounts of specific templates for each gene including 18S to calculate the number of mRNA copies in each sample.
Primary granular cell cultures
All media were purchased from Invitrogen. The cerebella were dissected from P6-P7 Wt and Mct8KO mice in Hanks' balanced sodium salt solution, without Ca 2ϩ and Mg 2ϩ , supplemented with 1 mM Na pyruvate and 10 mM HEPES (pH 7.4). The tissue was disaggregated by passing through a 0.9-mm syringe, rinsed in Hanks' balanced sodium salt solution/pyruvate/HEPES and resuspended in serum-free culture medium (neurobasal medium supplemented with 2% B27, 0.5 mM glutamine, 10 U/ml penicillin, and 10 U/ml streptomycin) before seeding on poly-L-ornithine (Sigma)-coated 12-well multiwells (Sigma; 2.5 ϫ 10 5 cells/well). After 4 d, the granular cells were incubated for 24 h in the absence or presence or T 3 (Sigma) (from 0.2 to 5 nM) in the same medium containing 0.1% newborn calf serum deprived of thyroid hormones. Astrocyte contamination of the cultures was 3% as determined by immunofluorescence. Cells plated on glass coverslips were fixed with 4% paraformaldehyde for 5 min and permeabilized with 0.2% Triton X-100 in PBS for 5 min and then with methanol at Ϫ20 C for 2 min. After blocking with 5% nonimmune serum (Vector Laboratories, Burlingame, CA), the cells were doubly stained by overnight incubation at 4 C with the following combination of primary antibodies diluted 1:2000: rabbit polyclonal antiglial fibrillary acidic protein (Dako, Glostrup, Denmark) for astrocytes and mouse monoclonal anti-NeuN (Chemicon, Temecula, CA) for neurons. Nuclei were labeled with the nuclear stain 4Ј, 6-diamidino-2-phenylindole dihydrochloride.
Statistical calculations
Differences between means were obtained by two-way ANOVA, with the two factors being genotype and thyroidal state. As post hoc test, we used the Bonferroni tests using the Graph-Pad Prism software (http://www.graphpad.com/prism/).
Results
In this study we examined the relative effects of low doses of T 4 , and T 3 , administered to hypothyroid Wt and Mct8-deficient mice. The goal of this study was to evaluate the relative role of Mct8 in the transport of T 4 and T 3 in the brain in vivo by determining the effects of the hormones on cerebellar structure and the expression of thyroid hormone-regulated genes. Preliminary studies using morphological techniques failed to reveal consistent differences between age-matched, Wt, and KO mice during development that could be related to deficient thyroid hormone transport into the brain. Although not shown in this paper, we examined the laminar structure of the cerebral cortex, myelin protein expression, maturation of glial cells and different classes of interneurons and Purkinje cells, and number of interneuron precursors in the cerebellum and found no consistent deficits in the KO mice. These observations agree with previous studies reporting no obvious phenotype of cerebral hypothyroidism in these mice (6, 7) .
The next question we addressed was whether the absence of the Mct8 transporter impaired the biological activities of exogenous T 4 and T 3 selectively. Wt and KO mice were made hypothyroid by administration of antithyroid drugs and received 20 ng/g T 4 or 3 ng/g T 3 daily for 5 d before the animals were killed on P21. This dosage schedule was sufficient to completely correct the delayed migration of granular cells in the cerebellum of hypothyroid mice, as shown in Fig. 1 : Cerebellar sections from each group of mice were stained and examined by optical microscopy. Migration of granular cells was already completed in the euthyroid Wt animals by P21 so that the external germinal layer (EGL) was absent. As expected, the EGL was still present in the hypothyroid Wt mice at this age. Both T 4 and T 3 treatments were equally able to prevent the effects of hypothyroidism in the Wt mice.
In the absence of Mct8, the structure of the cerebellar cortex in the untreated KO mice was identical with that of the Wt mice, with no EGL remaining, illustrating the lack of morphological developmental abnormalities. As in the hypothyroid Wt mice, the EGL was still present in the hypothyroid KO P21 mice. T 4 treatment prevented the effects of hypothyroidism. However, in contrast to the effect on Wt mice, T 3 treatment did not correct the migration abnormality.
To examine the effects of T 4 , and T 3 on gene expression, two well-known thyroid hormone target genes, Nrgn in the striatum, and Hr in the cerebellum, were examined by real-time PCR. The results are shown in Fig. 2 . Interestingly and despite the lack of morphological impairment, Hr expression was decreased in the cerebellum of untreated KO mice with respect to the Wt mice, with levels similar to those present in WT hypothyroid mice. Induction of hypothyroidism decreased Hr expression further in 3 . Wt and KO mice were made hypothyroid (Hypo) from the late fetal period up to P21, and treated with either vehicle or T 4 or T 3 for 5 d before the animals were killed. Data are means Ϯ SD. Hr and RC3/Nrgn expression was analyzed by real-time PCR in the cerebellum and striatum, respectively. The data were analyzed by two-way ANOVA and the Bonferroni posttest to compare the data from each KO condition with the corresponding Wt. **, P Ͻ 0.01; ***, P Ͻ 0.001. For Hr expression, there was a significant effect of genotype (F 1,41 ϭ 116.01, P Ͻ 0.0001) and thyroidal status (F 3,41 ϭ 37.84, P Ͻ 0.0001), with a significant interaction (F 3,41 ϭ 3.88, P ϭ 0.0156). Also for Nrgn, there was a significant effect of genotype (F 1,35 ϭ 24.68, P Ͻ 0.0001) and thyroidal status (F 3,35 ϭ 41.16, P Ͻ 0.0001), with a significant interaction (F 3,35 ϭ 10.30, P Ͻ 0.0001). The lower panel shows Gpd2 expression in the liver. There was a significant effect of thyroidal status (F 3,41 ϭ 23.67, P Ͻ 0.0001) but not genotype (F 3,41 ϭ 1.065, P ϭ 0.308), with a significant interaction (F 3,41 ϭ 3.936, P Ͻ 0.0148). NS, Not significant. Nrgn expression was also lower in the untreated KO than the Wt mice and decreased further with hypothyroidism. In contrast to Hr, the hypothyroid Wt and KO mice had similar Nrgn mRNA levels. Although neither T 4 nor T 3 treatment were able to fully normalize Nrgn expression, again there was a significant difference between the responses to T 3 between the Wt and the KO mice but no difference in the responses to T 4 .
FIG. 2. Influence of Mct8 deficit on the response to T 4 and T
The liver mRNA Gpd2 (encoding mitochondrial ␣-glycerol phosphate dehydrogenase) was increased in the untreated KO mice relative to the untreated Wt mice. Hypothyroidism decreased Gpd2 expression in both genotypes (P Ͻ 0.001). T 4 and T 3 significantly increased the Gpd2 mRNA level compared with hypothyroid mice (P Ͻ 0.05). This increase was of similar magnitude in both genotypes and with both hormones.
To correlate the effects of thyroid hormones on Hr and Nrgn gene expression with Mct8 gene expression, we performed in situ mRNA hybridization (Fig. 3) . The Mct8 gene was heavily expressed in the choroid plexus (Fig. 3, A-C) and the ependymal lining of the third ventricle (Fig. 3B) . Other sites of expression were the upper layers of the cerebral cortex, especially the cingulate, visceral, and piriform cortices; the pyramidal and granular layers of the hippocampus; and the amygdala (Fig. 3B) . In the cerebellum, besides expression in the choroid plexus, Mct8 mRNA had low but detectable abundance in the cerebellar cortex. In the striatum Mct8 was poorly expressed (Fig. 3A) . Figure  3D shows Nrgn mRNA, which is abundantly present after a lateral-medial gradient, contrasting with the poor expression of Mct8. The effect of Mct8 gene deletion (Fig. 3E) did not affect the Nrgn mRNA signal gradient, in contrast to the effect of hypothyroidism (not shown, but see Ref. 14) , which results in a total suppression of the gradient. Interestingly, Dio2 mRNA distribution in the striatum (Fig.3F ) also followed a similar gradient, with no changes in the pattern of distribution in the Mct8 KO mice (not shown). The lack of correlation between the sites of expression of Mct8 with that of the T 3 -target genes, Nrgn and Hr, indicate that Mct8 might be playing a minor role in thyroid hormone transport through the plasma membrane of cerebellar granular cells and striatal neurons in vivo.
To address this question more directly, we studied transporter expression and Hr induction by T 3 in primary cultures of neurons. Granular cells from newborn mice cerebella were cultured. To analyze the effect of Mct8 deficit on the effect of T 3 on Hr gene induction, T 3 was added to granular cells from Wt and KO mice, and Hr mRNA was measured by quantitative PCR. One representative experiment using different concentrations of T 3 is shown in Fig. 4 . Starting at the lowest concentration used, 0.2 nM, all T 3 concentrations gave a significant stimulation of Hr expression (P Ͻ 0.001) in both the Wt and KO cells. There were no significant differences in the effect of T 3 in the KO mice as compared with the Wt except for the 1.25 nM T 3 concentration in this particular experiment.
We also examined the profile of transporter expression in the same cultures used to analyze the effect of T 3 on Hr. We measured the amounts of mRNA of organic anion-transporting polypeptide (Oatp)-2 (Slco1a4), Oatp14 (Slc1c1), and Mct8 (Table 1). Granular cells from Wt cells expressed predominantly Mct8 (591 Ϯ 130 mRNA copies, relative to 18S RNA), which was undetectable in the KO cells. Oatp2 and Oatp14 were expressed at much lower levels (27.0 Ϯ 9.1 and 7.4 Ϯ 3.4, respec- tively). There were no changes in the KO compared with the Wt, and T 3 treatment had no effects on transporter expression, except for the higher dose, which decreased Oatp14 mRNA in the KO mice.
Discussion
The main finding of the present work is that the brain of animals lacking the thyroid hormone transporter Mct8 do not readily respond to a low dose of T 3 , whereas the sensitivity to an equally low dose of T 4 is similar to that of Wt animals. Five nanograms per gram T 3 were previously shown to normalize circulating TSH and hypothalamic TRH transcripts in hypothyroid Wt but not hypothyroid Mct8KO mice (7). We used low doses of T 4 and T 3 to avoid inhibition of Dio2 by T 4 and the use of low-affinity transporters by T 3 . Although, based on Gpd2 gene expression, the doses used did not fully restore euthyroidism in the Wt mice liver, they were sufficient to normalize cerebellar development, EGL migration, and Hr expression in the Wt hypothyroid mice. In contrast, they were insufficient for Nrgn mRNA normalization.
In normal animals, T 3 reaches the extracellular fluid of the brain parenchyma from the circulation through the blood-brain barrier and acts directly on the neurons. T 4 may exert some extranuclear actions, but the bulk of genomic responses are mediated by its conversion to T 3 by Dio2. In the brain, this reaction takes place predominantly in glial cells, namely astrocytes, and IV ventricle tanycytes, although Dio2 expression has also been observed in some cerebral cortex interneurons as a response to hypothyroidism (13, 15) .
In the developing cerebellum, T 4 to T 3 conversion takes place in the protoplasmic astrocytes located within the granular layer in close association to the granular cells. Because there was no difference in the effects of T 4 in KO vs. Wt mice, the results suggest that, in the doses used, T 4 could reach the cerebellar astrocytes of Mct8-deficient mice in sufficient amount to produce the effects observed in Wt mice. This event is further facilitated by the great increase of Dio2 activity in the brain of Mct8 KO mice (6, 7) . In addition, the results also suggest that the T 3 produced in astrocytes can access the granular cell nuclear receptors with little restriction at the neuronal cell membrane.
The effects of T 3 on granular cells in culture agree with the above conclusion. These results agree with the preferential accumulation of administered T 4 , relative to the restricted accumulation of administered T 3 in the brain of Mct8 KO mice (6, 7). Brain T 3 concentrations in the KO mice were about two thirds of normal. Given the restriction to T 3 entry, most T 3 in the brain of these animals must be derived from T 4 .
The main site of Mct8 expression is the choroid plexus. The consequences of the absence of Mct8 in the choroid plexus are not known. Intrathecally administered T 4 and T 3 can access brain structures (16) . However, most studies on the routes of thyroid hormone entry to the brain agree that the cerebrospinal fluid allows only limited access of thyroid hormone to the brain parenchyma, preferentially reaching cells located near the surface of the ventricles (17, 18) . Therefore, the main access of thyroid hormone to the brain parenchyma is through the bloodbrain barrier. In keeping with this concept, our data suggest that the restriction of T 3 entry in Mct8-deficient mice is at the bloodbrain barrier. Indeed Mct8 has been recently demonstrated in the membrane of the brain parenchyma capillaries (9) . The presence of other transporters such as Oatp14 and Oatp2, with more affinity for T 4 than T 3 may explain the different sensitivities to T 4 and T 3 . Whereas normal T 4 uptake may preserve the compensated phenotype in mice, the lack of alternative transporters in the human blood-brain barrier would be the reason for the neurological impairment (9) .
In conclusion, the data show that the main restriction to T 3 action in the absence of Mct8 is at the level of the blood-brain barrier. The thyroid hormone transport role of Mct8 in the plasma membrane of neurons, at least in the striatum and the cerebellum, seems to be minimal.
